Institution
University of Arkansas
Education•Fayetteville, Arkansas, United States•
About: University of Arkansas is a education organization based out in Fayetteville, Arkansas, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 17225 authors who have published 33329 publications receiving 941102 citations. The organization is also known as: Arkansas & UA.
Topics: Population, Poison control, Context (language use), Quantum dot, Broiler
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this article, the authors investigated the changes in selected antioxidants in rice bran from both long and medium-grain rice during commercial milling and bran processing and found that bran collected from various milling breaks of a commercial system had varying antioxidant levels.
Abstract: Rice bran contains high amounts of beneficial antioxidants including tocopherols, tocotrienols, and oryzanols. Current rice milling technology produces rice bran from different layers of the kernel caryopsis. Under current practices, these layers are combined and then steam-extruded to form a stabilized rice bran pellet that is storage-safe prior to oil extraction. Each of these rice bran intermediates can vary in antioxidant content. The objective of this study was to investigate the changes in selected antioxidants in rice bran from both long- and medium-grain rice during commercial milling and bran processing. Rice bran collected from various milling breaks of a commercial system had varying antioxidant levels. Bran collected after milling break 2 had the highest levels of tocopherol and tocotrienol. Oryzanol concentration was significantly higher in outer bran layers. Results also indicate that the long-grain rice bran averaged ≈15% more antioxidants than the medium-grain rice bran.
184 citations
••
TL;DR: Sufficient concentrations of an appropriate bacteriophage, or a bacteriophile mixture, can significantly reduce recoverable Salmonella from carcass rinses.
184 citations
••
TL;DR: Itraconazole is the initial treatment of choice for nonlife-threatening non-CNS blastomycosis, and the azoles are an equally effective and less toxic alternative to amphotericin B for treating immunocompetent patients with mild to moderate pulmonary or extrapulmonary disease, excluding CNS disease.
Abstract: Guidelines for the treatment of blastomycosis are presented; these guidelines are the consensus opinion of an expert panel representing the National Institute of Allergy and Infectious Diseases Mycoses Study Group and the Infectious Diseases Society of America. The clinical spectrum of blastomycosis is varied, including asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease. Most patients with blastomycosis will require therapy. Spontaneous cures may occur in some immunocompetent individuals with acute pulmonary blastomycosis. Thus, in a case of disease limited to the lungs, cure may have occurred before the diagnosis is made and without treatment; such a patient should be followed up closely for evidence of disease progression or dissemination. In contrast, all patients who are immunocompromised, have progressive pulmonary disease, or have extrapulmonary disease must be treated. Treatment options include amphotericin B, ketoconazole, itraconazole, and fluconazole. Amphotericin B is the treatment of choice for patients who are immunocompromised, have life-threatening or central nervous system (CNS) disease, or for whom azole treatment has failed. In addition, amphotericin B is the only drug approved for treating blastomycosis in pregnant women. The azoles are an equally effective and less toxic alternative to amphotericin B for treating immunocompetent patients with mild to moderate pulmonary or extrapulmonary disease, excluding CNS disease. Although there are no comparative trials, itraconazole appears more efficacious than either ketoconazole or fluconazole. Thus, itraconazole is the initial treatment of choice for nonlife-threatening non-CNS blastomycosis.
184 citations
••
TL;DR: Switchgrass populations for use in biomass production, conservation, or restoration should not be moved more than one hardiness zone north or south from their origin, but some can be moved east or west of their original ecore- gion, if results from tests support broad longitudinal adaptation.
Abstract: Switchgrass (Panicum virgatum L.) is a warm- season native grass, used for livestock feed, bioenergy, soil and wildlife conservation, and prairie restoration in a large portion of the USA. The objective of this research was to quantify the relative importance of latitude and longitude for adaptation and agronomic performance of a diverse group of switchgrass populations. Six populations, chosen to represent remnant prai- rie populations on two north-south transects, were evaluated for agronomic traits at 12 loca- tions ranging from 36 to 47°N latitude and 88 to 101°W longitude. Although the population × location interactions accounted for only 10 to 31% of the variance among population means, many signifi cant changes in ranking and adap- tive responses were observed. Ground cover was greater for northern-origin populations evaluated in hardiness zones 3 and 4 and for southern-origin populations evaluated in har- diness zones 5 and 6. There were no adaptive responses related to longitude (ecoregion). Switchgrass populations for use in biomass production, conservation, or restoration should not be moved more than one hardiness zone north or south from their origin, but some can be moved east or west of their original ecore- gion, if results from fi eld tests support broad longitudinal adaptation.
184 citations
••
TL;DR: In 1995, an antibiotic (ANT) was used in starter, grower, and withdrawal (WD) feeds by 94.3, 98.2, and 75.1% of broiler production units, but by 2000, ANT use had declined, but use of ION + ROX + ANT increased, and there were no significant differences in calorie conversion.
183 citations
Authors
Showing all 17387 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert M. Califf | 196 | 1561 | 167961 |
Hugh A. Sampson | 147 | 816 | 76492 |
Stephen Boyd | 138 | 822 | 151205 |
Nikhil C. Munshi | 134 | 906 | 67349 |
Jian-Guo Bian | 128 | 1219 | 80964 |
Bart Barlogie | 126 | 779 | 57803 |
Robert R. Wolfe | 124 | 566 | 54000 |
Daniel B. Mark | 124 | 576 | 78385 |
E. Magnus Ohman | 124 | 622 | 68976 |
Benoît Roux | 120 | 493 | 62215 |
Robert C. Haddon | 112 | 577 | 52712 |
Rodney J. Bartlett | 109 | 700 | 56154 |
Baoshan Xing | 109 | 823 | 48944 |
Gareth J. Morgan | 109 | 1019 | 52957 |
Josep Dalmau | 108 | 568 | 49331 |